These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23830236)

  • 1. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
    Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
    Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.
    Nurminen R; Rantapero T; Wong SC; Fischer D; Lehtonen R; Tammela TL; Nykter M; Visakorpi T; Wahlfors T; Schleutker J
    Genes Chromosomes Cancer; 2016 Aug; 55(8):661-73. PubMed ID: 27113481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an aggressive prostate cancer predisposing variant at 11q13.
    Nurminen R; Wahlfors T; Tammela TL; Schleutker J
    Int J Cancer; 2011 Aug; 129(3):599-606. PubMed ID: 21064104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ-line alterations in MSR1 gene and prostate cancer risk.
    Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
    Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
    Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
    Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
    Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
    Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
    Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
    Laitinen VH; Rantapero T; Fischer D; Vuorinen EM; Tammela TL; ; Wahlfors T; Schleutker J
    Int J Cancer; 2015 May; 136(10):2316-27. PubMed ID: 25335771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
    Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
    Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer.
    Camp NJ; Swensen J; Horne BD; Farnham JM; Thomas A; Cannon-Albright LA; Tavtigian SV
    Genet Epidemiol; 2005 Apr; 28(3):232-43. PubMed ID: 15593091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
    Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
    Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
    Kote-Jarai Z; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Dadaev T; Jugurnauth-Little S; Ross-Adams H; Al Olama AA; Benlloch S; Halim S; Russell R; Dunning AM; Luccarini C; Dennis J; Neal DE; Hamdy FC; Donovan JL; Muir K; Giles GG; Severi G; Wiklund F; Gronberg H; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Canzian F; Riboli E; Key TJ; Travis RC; Campa D; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Vogel W; Kibel AS; Cybulski C; Lubinski J; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Spurdle A; Clements JA; Teixeira MR; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Dicks E; Baynes C; Conroy D; Bojesen SE; Kaaks R; Vincent D; Bacot F; Tessier DC; ; ; ; ; Easton DF; Eeles RA
    Hum Mol Genet; 2013 Jun; 22(12):2520-8. PubMed ID: 23535824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
    Wang L; McDonnell SK; Slusser JP; Hebbring SJ; Cunningham JM; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2007 Apr; 67(7):2944-50. PubMed ID: 17409399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.
    Tindall EA; Severi G; Hoang HN; Ma CS; Fernandez P; Southey MC; English DR; Hopper JL; Heyns CF; Tangye SG; Giles GG; Hayes VM;
    Carcinogenesis; 2010 Oct; 31(10):1748-54. PubMed ID: 20403914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of MUC1 genetic variation on prostate cancer risk and survival.
    Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
    Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.